Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Lane (1992)p53, guardian of the genome
Jm Varley, D. Evans, J. Birch (1997)Li-Fraumeni syndrome--a molecular and clinical review.
British Journal of Cancer, 76
A. Salmon, D. Amikam, N. Sodha, S. Davidson, Lina Basel-Vanagaite, R. Eeles, Dvorah Abeliovich, T. Peretz (2007)Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
Clinical oncology (Royal College of Radiologists (Great Britain)), 19 7
T. Frebourg, N. Barbier, Y. Yan, J. Garber, M. Dreyfus, J. Fraumeni, F. Li, S. Friend (1995)Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
American journal of human genetics, 56 3
J. Birch, R. Alston, R. McNally, D. Evans, A. Kelsey, M. Harris, O. Eden, J. Varley (2001)Relative frequency and morphology of cancers in carriers of germline TP53 mutations
M. Olivier, R. Eeles, M. Hollstein, Mohammed Khan, C. Harris, P. Hainaut (2002)The IARC TP53 database: New online mutation analysis and recommendations to users
Human Mutation, 19
A. Petitjean, E. Mathé, S. Kato, C. Ishioka, S. Tavtigian, P. Hainaut, M. Olivier (2007)Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database
Human Mutation, 28
C. Monnerat, A. Chompret, C. Kannengiesser, M. Avril, N. Janin, A. Spatz, J. Guinebretière, C. Marian, M. Barrois, F. Boitier, G. Lenoir, B. Paillerets (2007)BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
Familial Cancer, 6
J. Limacher, T. Frebourg, S. Natarajan‐Amé, J. Bergerat (2001)Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
International Journal of Cancer, 96
C. Nutting, R. Camplejohn, R. Gilchrist, D. Tait, P. Blake, G. Knee, W. Yao, G. Ross, C. Fisher, R. Eeles (2000)A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?
Clinical oncology (Royal College of Radiologists (Great Britain)), 12 5
D. Lane (1992)Cancer. p53, guardian of the genome.
Nature, 358 6381
J. Tinat, G. Bougeard, S. Baert-Desurmont, S. Vasseur, Cosette Martin, E. Bouvignies, O. Caron, B. Paillerets, P. Berthet, C. Dugast, C. Bonaïti‐pellié, D. Stoppa-Lyonnet, T. Frebourg (2009)2009 version of the Chompret criteria for Li Fraumeni syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 26
A. Shlien, U. Tabori, C. Marshall, M. Pienkowska, L. Feuk, A. Novokmet, Sonia Nanda, H. Druker, S. Scherer, D. Malkin (2008)Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
Proceedings of the National Academy of Sciences, 105
M. Olivier, D. Goldgar, N. Sodha, H. Ohgaki, P. Kleihues, P. Hainaut, R. Eeles (2003)Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Cancer research, 63 20
G. Bond, Wenwei Hu, E. Bond, Harlan Robins, Stuart Lutzker, N. Arva, J. Bargonetti, F. Bartel, Helge Taubert, Peter Wuerl, Kenan Onel, Linwah Yip, Shih-Jen Hwang, Louise Strong, G. Lozano, Arnold Levine (2004)A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
Y. Horio, H. Suzuki, R. Ueda, T. Koshikawa, T. Sugiura, Y. Ariyoshi, K. Shimokata, T. Takahashi (1994)Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.
Oncogene, 9 4
Ines Bendig, Nicole Mohr, F. Kramer, B. Weber (2004)Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
Cancer genetics and cytogenetics, 154 1
Frederick Li, J. Fraumeni, J. Mulvihill, W. Blattner, M. Dreyfus, M. Tucker, Robert Miller (1988)A cancer family syndrome in twenty-four kindreds.
Cancer research, 48 18
A. Chompret, A. Abel, D. Stoppa-Lyonnet, L. Brugières, S. Pagès, J. Feunteun, C. Bonaïti‐pellié (2001)Sensitivity and predictive value of criteria for p53germline mutation screening
Journal of Medical Genetics, 38
J. Varley, G. McGown, M. Thorncroft, L. James, G. Margison, Gill Forster, D. Evans, M. Harris, A. Kelsey, J. Birch (1999)Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
American journal of human genetics, 65 4
P. Wong, S. Verselis, J. Garber, K. Schneider, L. Digianni, David Stockwell, Frederick Li, S. Syngal (2006)Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
Gastroenterology, 130 1
J. Boyle, A. Spreadborough, M. Greaves, J. Birch, J. Varley, D. Scott (2002)Delayed Chromosome Changes in Gamma-Irradiated Normal and Li-Fraumeni Fibroblasts
P. Vahteristo, A. Tamminen, Petteri Karvinen, H. Eerola, C. Eklund, L. Aaltonen, C. Blomqvist, K. Aittomäki, H. Nevanlinna (2001)p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
Cancer research, 61 15
M. Hisada, J. Garber, Frederick Li, C. Fung, J. Fraumeni (1998)Multiple primary cancers in families with Li-Fraumeni syndrome.
Journal of the National Cancer Institute, 90 8
T. Trahair, L. Andrews, R. Cohn (2007)Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma
Pediatric Blood & Cancer, 48
J. Reifenberger, G. Janssen, R. Weber, J. Bostrom, V. Engelbrecht, P. Lichter, F. Borchard, U. Gobel, G. Reifenberger (1998)Primitive Neuroectodermal Tumors of the Cerebral Hemispheres in Two Siblings with TP53 Germline Mutation
Journal of Neuropathology and Experimental Neurology, 57
G. Bougeard, L. Brugières, A. Chompret, P. Gesta, F. Charbonnier, A. Valent, Cosette Martin, G. Raux, J. Feunteun, B. Paillerets, T. Frebourg (2003)Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene
K. Gonzalez, Katie Noltner, C. Buzin, D. Gu, Cindy Wen-Fong, V. Nguyen, Jennifer Han, K. Lowstuter, J. Longmate, S. Sommer, J. Weitzel (2009)Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 8
We report a 26-year-old female patient who was diagnosed within 4 years with chest sarcoma, lung adenocarcinoma, and breast cancer. While her family history was unremarkable, DNA sequencing of TP53 revealed a germline de novo non-sense mutation in exon 6 p.Arg213X. One year later, she further developed a contralateral ductal carcinoma in situ, and 18 months later a jaw osteosarcoma. This case illustrates the therapeutic pitfalls in the care of a young cancer patient with TP53 de novo germline mutations and the complications related to her first-line therapy. Suggestion is made to use the less stringent Chompret criteria for germline TP53 mutation screening. Our observation underlines the possibly negative effect of radiotherapy in generating second tumors in patients with a TP53 mutation. We also present a review of six previously reported cases, comparing their cancer phenotypes with those generally produced by TP53 mutations.
Familial Cancer – Springer Journals
Published: Jan 12, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.